on BIOSYNEX (EPA:ALBIO)
BIOSYNEX SA victim of a cyberattack
BIOSYNEX, a company active in the field of health diagnostics, announced that it suffered a cyberattack between July 31 and August 2, 2026. In response to this incident, BIOSYNEX immediately implemented measures to limit the impact of this intrusion and strengthened the security of its IT platforms.
A thorough investigation is underway to assess the extent of the attack. At this stage, the compromised data appears to be limited to business information. BIOSYNEX has notified the authorities, including the CNIL (French Data Protection Authority), and continues to keep its partners informed of the situation.
The company's operations were reportedly not affected by this incident. A complaint has been filed with the judicial authorities.
R. H.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all BIOSYNEX news